Osaka Soda Co (4046) Q1 2026 earnings summary

Executive summary

• Net sales for the first three months ended June 30, 2025, rose 0.7% year-on-year to ¥24,284 million, with operating profit up 19.0% to ¥3,939 million and profit attributable to owners of parent up 9.4% to ¥3,047 million.

• The company advanced its medium-term plan, focusing on strengthening existing businesses, new product development, and sustainability management.

• Healthcare segment benefited from strong demand for pharmaceutical purification materials, while new facilities began commercial production ahead of schedule.

Financial highlights

• Operating profit margin improved, with gross profit up to ¥7,782 million from ¥7,007 million year-on-year.

• Comprehensive income for the quarter was ¥3,283 million, down 13.6% year-on-year.

• Basic earnings per share for the quarter were ¥24.22, calculated post-stock split.

• Total assets at June 30, 2025, were ¥153,236 million, down 0.5% from March 31, 2025.

• Net assets increased 1.5% to ¥117,272 million, with equity-to-asset ratio at 76.5%.

Outlook and guidance

• Full-year forecast for FY ending March 2026: net sales ¥102,000 million (+5.8% YoY), operating profit ¥17,000 million (+28.3%), profit attributable to owners of parent ¥12,300 million (+19.0%), EPS ¥97.70.

• No changes to previously announced forecasts; company will update as needed.